Related references
Note: Only part of the references are listed.Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort
Rekha Lopez et al.
RHEUMATOLOGY (2012)
Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period
Amanda J. Steiman et al.
ARTHRITIS CARE & RESEARCH (2012)
Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
Sharon A. Chambers et al.
RHEUMATOLOGY (2009)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
Graciela S. Alarcon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus
Glinda S. Cooper et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus
K. P. Ng et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
DA Isenberg et al.
RHEUMATOLOGY (2005)
Definition and treatment of lupus flares measured by the BILAG index
C Gordon et al.
RHEUMATOLOGY (2003)
Share Paper
